Latest News
Enterprise Ireland client companies announce the creation over 1000 new jobs
Irish Stock Exchange announces #IPOready initiative
382 actions set out in Government's 2015 plan for jobs
Fountain Healthcare Partners to manage €85m VC Fund
Research & Innovation
€25m investment in Dairy Processing Technology Centre
Baileys €600k innovation partnership with Enterprise Ireland
Bowel cancer blood test 'breakthrough'
World's first bone repair technology developed by Irish scientists saves horse's life
Startup Zone
The Start-up Class of 2014 comes to Dublin Castle
Irish start-up HiberGene Diagnostics raises €2m to commercialize tests for rapid diagnosis of critical diseases
PayPal and Dunnhumby back mobile location marketing start-up Pulsate
Irish space start-up gets €800,000 in ESA funding for big data in the cosmos
International Activities
Oneview Healthcare signs its first deal in the Middle East
New export guide to support companies reaching for new horizons
Irish healthcare companies exhibit at Arab Health
Upcoming Events
Mobile World Congress 2015
Arab Irish Business Forum - Focus on the Gulf
Pet Care Market Innovation Event
Tech Town at Career Zoo – 21st February
Contact Us  Follow Us
Start-ups, Jobs, Deals

Irish start-up HiberGene Diagnostics raises €2m to commercialize tests for rapid diagnosis of critical diseases


Pictured (L-R) are: Dawn Walsh, Marketing Executive, Kernel Capital; Brendan Farrell, CEO, HiberGene Diagnostics; Kevin Healy, Manager, Corporate Banking Ireland, Bank of Ireland and Margot Marsden, Senior Development Advisor, Enterprise Ireland.

Dublin-based medical diagnostics company HiberGene Diagnostics has secured a €2m investment, which will be used to support the commercialisation of its first two molecular tests for Meningococcal Meningitis and Group B Streptococcus (GBS).

Kernel Capital announced the syndicated investment comprising of a €500,000 investment by the Bank of Ireland MedTech Accelerator Fund with the remainder of funds provided by Enterprise Ireland and private investors.

A spin-out from the Royal Victoria Hospital in Belfast, HiberGene is developing a range of molecular diagnostics tests which will enable the rapid diagnosis of multiple infectious diseases.

HiberGene’s diagnostic tests developed utilising loop mediated isothermal amplification (Lamp) enabling technology will enable the diagnosis of patients in near-patient settings such as clinical laboratories, emergency rooms and delivery wards producing positive results within ten minutes.
HiberGene are planning significant recruitment over the next twelve months to support their growth plans.

Brendan Farrell, CEO, HiberGene Diagnostics said: “We are now ready to fully commercialise our first two products and to commence development of Lamp-based tests for other infectious diseases. Both the meningitis and Group B Streptococcus products meet a currently unmet clinical need for rapid and accurate testing.”

Facebook Twitter LinkedIn Del.icio.us
Email Software by Newsweaver